Menu
Home
TMU
FAQ
Sitemap
正體中文
News
Announcements
Events
Business
FAQ
FAQ: IRB
FAQ: Clinical Trial
FAQ: Biobank
Charges
Public Area
About OHR
OHR Overview
Dean
OHR Members
Department
JIRB Administration Section
Data Safety Managing Section
Joint Clinical Research Center
Joint Biobank
Business
Clinical Trial
Clinical Trial Agreement
Investigator-Initiated Trial
Project Writing Consultation
Ongoing Clinical Trials
Biobank
Biobank Application
Charges
TMU-JIRB
About TMU-JIRB
Introduction
Members
SOP
Application System
TMU-eJIRB System
IRB Account Controller Application
Application Process
Charges
Meeting Date
FAQs
Download
Forms
Clinical Trial
Regulation
TMU Regulation
Domestic Regulation
Related Regulation
Links
Online Portals
TMU Online Resources
External Online Resources
Affiliated Hospitals
REACTA 2024
Contact
Contact Info
Website Feedback Form
Home
Ongoing Clinical Trials
Ongoing Clinical Trials
Indication
All
overweight and obesity
Esophagus:process
Knee Osteoarthritis (KOA)
Pancreatic Cancer
Dermatosis/skin disease
Cell Therapy
Asthma
Solid tumors
Chronic obstructive pulmonary disease (COPD)
Rhinosinusitis
Lung Cancer
Endometriosis
Diabetes
Hepatitis B or D Infection
Hepatocellular Carcinoma (HCC)
Pregnant Women
Non-Alcoholic Fatty Liver
Healthy Volunteer
Systemic Lupus Erythematosus
Sjögren’s syndrome (NEPTUNUS-2)
Gout
COVID-20
Hemodialysis
Chronic Kidney Disease
Chronic Kidney Disease
heart failure
major adverse cardiovascular events
Coronary Syndrome
Spinal Cord Injuries (SCI)
High Blood Pressure/Hypertension
Hypercholesterolemia
Urinary Tract Infections
Influenza Vaccine
COVID-21
Breast Cancer
Cancer Patients
Interstitial lung disease
Femtosecond Ophthalmic
Chronic Kidney Disease (CKD)
Melanoma
Tibial fracture
COVID-19
Acute Respiratory Syncytial Virus Infection
Viral Lung Infection Requiring Supplemental Oxygen (TILIA)
Focal segmental glomerulosclerosis (FSGS)
Nephropathy
Diabetes and Chronic Kidney Disease
chronic obstructive pulmonary disease (COPD)
Chronic Plaque Psoriasis
Atopic Dermatitis
Myasthenia Gravis
Proliferative Lupus Nephritis
Knee Osteoarthritis (KOA)
Ulcerative Colitis (UC)
Atrial fibrillation
Ischemic stroke
Persistent Cancer Pain
Institution
All
TMUH
WFH
SHH
Department
All
Colorectal Surgery
Oral Surgery
Orthopedics
Radiation Oncology
Dermatology
Plastic Surgery
Pulmonary Medicine/Sleep Clinic
Pulmonary Medicine
Obstetrics
Endocrinology and Metabolism
Gastroenterology
Pediatrics
Rheumatology
Family Medicine
Nephrology
Cardiology
Urology
Hematology and Oncology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Internal Medicine/Neurology
Hematology And Oncology
Cardiovascular Surgery
Infection
Neurology
Allergy, Immunology and Rheumatology
Principal Investigator
All
Wei Wang
Chia-Yu Wu
Jia-Lin, Wu
Long-Sheng Lu
Lee,Tsung-Ju
Li-Wei Tang
Pai-Chien Chou
Chao-Hua Chiu
Timothy Chiu
Shuen-Fu Weng
Wei-Yu Kao
Heng-Kien Au
Chun-Chao Chang
Chia-Yau Chang
Chi-Ching Chang
Shy-Shin Chang
Cheng Tiong
Han-Pin Kuo
Hsi-Hsien, Chen
Chun-Yao Huang
MING-CHE LIU
Yen-Lin Liu
Jia-Ruey Tsai
Yung-Hsiao,Chiang
Shih-Hsin Hsiao
Chi-Li Chung
Le-Ming Wang
Chien-Liang Wu
Jia-Ying Sung
Tzeon-Jye Chiou
Chun-Che Shih
Chia-Lun Chang
Kuo Yi-Jie
Fu-Lun Chen
Tsong-Yih Ou
Ming-Hsiung Hsieh
Mai-Szu Wu
Kang-Yun Lee
Woan-Ruoh Lee
Hou-Chang Chiu
Yu-Sheng Chang
Yung-Ho Hsu
Chih-Hwa Chen
Ming-Yao Chen
Chen Kuan-Yuan
Tzu-Tao Chen
Lung Chan
Po-Hao Feng
Chia-Lun Chou
Tsu-Yi Chao
Wei-Hong Cheng
Yao-Yu Hsieh
Protocol Title
Search
Clear
TMU-JIRB No.
Protocol Title
Indication
Institution
Department
Principal Investigator
Contact
N202303061
A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)
Lung Cancer
SHH
Pulmonary Medicine
Kang-Yun Lee
Rong-Wei Jhou
0963969166
N202312002
A Randomized, Double-Blind, Placebo-Controlled, Multi-Regional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy
Lung Cancer
SHH
Pulmonary Medicine
Kang-Yun Lee
Rong-Wei Jhou
0963969166
N201910049
A Phase I, Open label, dose escalation study to Evaluate The Safety and Tolerability after intravenous infusion of UMC119-06 in subjects with moderate chronic obstructive pulmonary disease (COPD)
chronic obstructive pulmonary disease (COPD)
SHH
Pulmonary Medicine
Kang-Yun Lee
Rong-Wei Jhou
0963969167
N202012035
Development of stem cell culture technology in vitro - Hair follicle and skin sample collection
Dermatosis/skin disease
SHH
Dermatology
Woan-Ruoh Lee
Lu-Fan Lai
0970747584 #2388
N202102073
Prospective Observational Cohort Study of Patients with Moderate to Severe Chronic Plaque Psoriasis in Taiwan
Chronic Plaque Psoriasis
SHH
Dermatology
Woan-Ruoh Lee
Lu-Fan Lai
0970747584 #2389
N202307012
An Open-Label multinational, multicenter study to evaluate the long-term safety, tolerability and efficacy of subcutaneous amlitelimab in adult participants with moderate to severe atopic dermatitis
Atopic Dermatitis
SHH
Dermatology
Woan-Ruoh Lee
Ya-Chun Chang
0976909019
N202212018
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis
Myasthenia Gravis
SHH
Neurology
Hou-Chang Chiu
Yi-Ping Ji
0958790027
N202212013
A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Anifrolumab in Asian Participants with Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
SHH
Allergy, Immunology and Rheumatology
Yu-Sheng Chang
Ci-Han Chen
0911913137
N202110016
A Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis
Proliferative Lupus Nephritis
SHH
Allergy, Immunology and Rheumatology
Yu-Sheng Chang
Ci-Han Chen
0911913138
N202203156
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy
Nephropathy
SHH
Nephrology
Yung-Ho Hsu
Yun-Hui Wang
0972223815
1
2
3
4
5
6
7
8
9
10
11
12
13
/
13
TOP